BRA
SNY icon

Biechele Royce Advisors’s Sanofi SNY Stock Holding History

Biechele Royce Advisors’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-38,773
Closed -$1.72M – 45
2019
Q1 		$1.72M Sell
38,773
-1,503
-4% -$64.4K 1.11% 25
2018
Q4 		$1.75M Sell
40,276
-1,103
-3% -$48.6K 1.26% 26
2018
Q3 		$1.85M Sell
41,379
-61,053
-60% -$2.61M 1.16% 28
2018
Q2 		$6.87M Buy
102,432
+68,843
+205% +$2.71M 4.6% 4
2018
Q1 		$1.35M Buy
33,589
+59
+0.2% +$2.46K 0.94% 32
2017
Q4 		$1.44M Buy
+33,530
New +$1.55M 0.98% 31

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Biechele Royce Advisors's SNY Position: Q2 2019 in Review

Biechele Royce Advisors sold out of Sanofi (SNY) in Q2 2019, closing a stake of 38,773 shares — an estimated $1.72M sold.

Biechele Royce Advisors first reported a position in SNY in Q4 2017 and held it in 6 quarters. The position peaked at $6.87M in Q2 2018. 482 funds tracked by Wall St. Rank hold SNY as of Q2 2019.

  • Biechele Royce Advisors reported no remaining Sanofi position as of Q2 2019 after selling out during the quarter.
  • Biechele Royce Advisors sold 38,773 Sanofi shares in Q2 2019, an estimated $1.72M.
  • Biechele Royce Advisors first reported a position in Sanofi in Q4 2017 and held it in 6 quarters.
  • Biechele Royce Advisors's Sanofi position peaked at $6.87M in Q2 2018.
  • 482 funds tracked by Wall St. Rank held Sanofi as of Q2 2019.

Based on Biechele Royce Advisors's 13F filing for Q2 2019, filed 16 Jul 2019.